Jonathan H Gillard Selected Research

Carotid Artery Diseases

1/2020	Ferumoxytol-enhanced three-dimensional magnetic resonance imaging of carotid atheroma- a feasibility and temporal dependence study.
7/2017	Imaging pathobiology of carotid atherosclerosis with ultrasmall superparamagnetic particles of iron oxide: an update.
2/2017	Natural History of Carotid Atherosclerosis in Relation to the Hemodynamic Environment.
10/2015	Use of ultrasmall superparamagnetic iron oxide particles for imaging carotid atherosclerosis.
6/2014	3D high-resolution contrast enhanced MRI of carotid atheroma--a technical update.
4/2013	Carotid stenosis assessment with multi-detector CT angiography: comparison between manual and automatic segmentation methods.
1/2013	Effect of low-and high-dose atorvastatin on carotid artery distensibility using carotid magnetic resonance imaging -a post-hoc sub group analysis of ATHEROMA (Atorvastatin Therapy: Effects On Reduction Of Macrophage Activity) Study.
1/2012	Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis.
1/2012	Evaluation of ultrasmall superparamagnetic iron oxide-enhanced MRI of carotid atherosclerosis to assess risk of cerebrovascular and cardiovascular events: follow-up of the ATHEROMA trial.
3/2011	Impact of plaque haemorrhage and its age on structural stresses in atherosclerotic plaques of patients with carotid artery disease: an MR imaging-based finite element simulation study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan H Gillard Research Topics

Disease

35	Atherosclerotic Plaque (Atheroma) 01/2020 - 07/2004
22	Pathologic Constriction (Stenosis) 01/2020 - 07/2004
17	Inflammation (Inflammations) 10/2022 - 12/2005
12	Carotid Stenosis (Carotid Artery Stenosis) 01/2020 - 07/2006
12	Carotid Artery Diseases 01/2020 - 03/2010
11	Rupture 01/2020 - 03/2006
8	Aneurysm (Aneurysms) 10/2022 - 06/2005
8	Thrombosis (Thrombus) 01/2020 - 12/2014
7	Hemorrhage 02/2017 - 09/2012
6	Atherosclerosis 02/2017 - 02/2007
5	Stroke (Strokes) 07/2015 - 01/2005
4	Aortic Aneurysm (Aneurysm, Aortic) 01/2017 - 11/2008
3	Abdominal Aortic Aneurysm 03/2018 - 11/2010
2	Neoplasms (Cancer) 01/2022 - 08/2012
2	Necrosis 08/2015 - 03/2007
1	Thoracic Aortic Aneurysm 10/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Myocardial Infarction 01/2016
1	Fibrosis (Cirrhosis) 08/2015
1	Acute Coronary Syndrome 05/2014
1	Acute Kidney Injury (Acute Renal Failure) 12/2013
1	Astrocytoma (Pilocytic Astrocytoma) 08/2012
1	Peripheral Arterial Disease 04/2011
1	Stable Angina 05/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2010
1	Fatigue 07/2009
1	Fistula 07/2008
1	False Aneurysm (Pseudoaneurysm) 07/2008
1	Glioma (Gliomas) 07/2007
1	Hypoxia (Hypoxemia) 07/2006
1	Transient Ischemic Attack 12/2005
1	Ischemic Stroke 01/2005
1	Infarction (Infarctions) 02/2004
1	Brain Hypoxia (Cerebral Hypoxia) 02/2004

Drug/Important Bio-Agent (IBA)

23	Phenobarbital (Luminal)FDA Link 01/2020 - 07/2004
17	LipidsIBA 02/2017 - 09/2004
14	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2020 - 07/2004
8	ferric oxide (iron oxide)IBA 07/2017 - 07/2004
7	ElementsIBA 05/2014 - 03/2006
6	Contrast MediaIBA 01/2020 - 07/2007
5	CalciumIBA 03/2018 - 01/2007
5	Atorvastatin (Lipitor)FDA Link 01/2013 - 06/2009
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 12/2005
3	Ferrosoferric Oxide (Magnetite)FDA Link 01/2020 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2009
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 08/2012
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 01/2016
2	oxidized low density lipoproteinIBA 02/2017 - 06/2009
2	IronIBA 10/2015 - 03/2008
2	Indicators and Reagents (Reagents)IBA 11/2010 - 07/2009
2	Oxygen (Dioxygen)IBA 07/2006 - 01/2005
1	CollagenIBA 10/2022
1	GlycosaminoglycansIBA 10/2022
1	ElastinIBA 10/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Lactate Dehydrogenase 5IBA 01/2022
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2022
1	CarbonIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	SolutionsIBA 11/2015
1	NitrogenIBA 11/2015
1	OxidesIBA 10/2015
1	Lipoproteins (Lipoprotein)IBA 08/2015
1	Cytidine Triphosphate (CTP)IBA 07/2015
1	GadoliniumIBA 06/2014
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2012
1	Warfarin (Coumadin)FDA LinkGeneric 12/2012
1	N-acetylaspartate (N-acetyl aspartate)IBA 08/2012
1	CreatineIBA 08/2012
1	Choline (Choline Chloride)IBA 08/2012
1	Acetylcysteine (Siran)FDA LinkGeneric 04/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2011
1	Muramidase (Lysozyme)IBA 05/2010
1	Blood Proteins (Serum Proteins)IBA 05/2010
1	Fc Receptors (Fc Receptor)IBA 03/2007
1	Superoxides (Superoxide)IBA 03/2007
1	Interleukin-6 (Interleukin 6)IBA 03/2007
1	CytokinesIBA 03/2007
1	Interleukin-12 (IL 12)IBA 03/2007
1	Interleukin-1beta (Interleukin 1 beta)IBA 03/2007
1	Flumazenil (Romazicon)FDA LinkGeneric 02/2004
1	fluoromisonidazoleIBA 02/2004

Therapy/Procedure

8	Therapeutics 01/2013 - 07/2006
7	Carotid Endarterectomy 11/2015 - 12/2005
3	Stents 01/2017 - 12/2012
1	Liver Transplantation 11/2015
1	Lasers (Laser) 05/2010
1	Treatment Delay 03/2010
1	Anesthesia 11/2008
1	Endovascular Procedures 07/2008
1	Drug Therapy (Chemotherapy) 02/2007
1	Endarterectomy (Thromboendarterectomy) 12/2005
1	Self-Help Devices (Assistive Technology) 06/2005